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Abstract.  A  membrane glycoprotein complex was iso- 
lated and purified from human smooth muscle by de- 
tergent solubilization and affinity chromatography on 
collagen-Sepharose.  The complex was identified as 
VLA-1 integrin and consisted of two subunits of 195 
and  130 kD in SDS-PAGE. Liposomes containing  the 
VLA-1  integrin adhered to surfaces coated with type I, 
II,  III, and IV collagens, Clq subcomponent of the 
first component of the complement,  and laminin.  The 
liposomes specifically adhered to these proteins in a 
Ca  2+, Mg2+-dependent manner,  but did not bind to 
gelatin,  fibronectin, and thrombospondin substrates. 
The expression of VLA-1  integrin  in different human 
tissues and cell types, and during aorta smooth muscle 
development was studied by SDS-PAGE, and subse- 
quent quantitative immunoblotting was performed with 
antibodies recognizing  al and fll subunits of the VLA-1 
integrin.  A  high level of VLA-1  integrin expression 
was an exceptional feature of smooth muscles.  Fibro- 
blasts, endothelial cells, keratinocytes,  striated 
muscles, and platelets contained trace amounts of 
VLA-1  integrin.  In the  10-wk-old human fetal aorta, 
VLA-1  integrin  was found only in smooth muscle cells 
whereas mesenchymal cells,  surrounding  aortic smooth 
muscle cells, were VLA-1  integrin  negative.  By the 
24th wk of gestation,  the amount of VLA-1 integrin 
was significantly reduced in the aortic media (4.3-fold 
for tXl subunit and 2.5-fold for fll  subunit) compared 
with that in the  10-wk-old aortic smooth muscle cells. 
After birth,  the expression of VLA-1  integrin in- 
creased and  in the  1.5-yr-old child aorta the VLA-1 
integrin level was almost the same as in adult aortic 
media.  Smooth muscle cells from intimal thickening 
of adult aorta express five times less ot~ subunit of 
VLA integrin that smooth muscle cells from adult aor- 
tic media.  In primary culture of aortic smooth muscle 
cells, the content of the VLA-1  integrin  was dramati- 
cally reduced and subcultured cells did not contain 
VLA-1  integrin at all. 
URING embryogenesis,  postnatal  development,  and 
atherogenesis,  smooth muscle cells (SMC) t under- 
go remarkable phenotypic transitions (40, 43). These 
processes are accompanied by a prominent coordinated reor- 
ganization  of cytoskeleton and extracellular  matrix  (2,  5, 
11-16, 26, 35, 39, 47). Cell surface receptors for extracellu- 
lar matrix proteins are directly involved in the integration  of 
extracellular matrix components with the cytoskeletal frame- 
work (4,  18, 23, 41, 42).  These transmembrane  receptors 
have been termed integrins  (23).  Extracellular domains of 
integrins  mediate cell adhesion to extracellular  matrix and 
basement membrane components and some plasma proteins. 
The cytoplasmic domains of integrins  are able to interact 
with actin filament-associated  proteins (1, 22). The integrins 
are heterodimers consisting  of an ot subunit linked noncova- 
l. Abbreviations  used in this paper:  SM, smooth muscle; SMC, smooth 
muscle cells; VLA, very late antigen. 
lently to a nonrelated/5  subunit.  Several different/5  subunits 
have been identified.  All/5 subunits  are structurally related 
to each other,  and they define different  subfamilies  of inte- 
grins (23). In humans,  the/st subfamily of integrins includes 
very late antigens  (VLA), initially  discovered on activated 
human T cells (18, 20). Later it was shown that VLA inte- 
grins are present on a wide variety of human cells (18). The 
VLA integrins  share  a common/51  subunit and at least six 
different ot subunits (18, 45, 48). A number of experimental 
data indicate that members of VLA (or B~) integrin  subfam- 
ily play an important role as mediators of cell adhesion  and 
migration  (4, 23, 42). Normal VLA integrin function is criti- 
cal for differentiation  and developmental  processes. It has 
been demonstrated that  an antibody to chicken/~l  integrin 
blocks myogenic differentiation  at the myoblast stage (32). 
We are particularly interested  in defining mechanisms that 
control SMC growth and differentiation,  with specific em- 
phasis on the role played by VLA integrins  in these pro- 
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and purified from chicken gizzard smooth muscle (SM) and 
rat arterial SMC (3, 25). The rat arterial SM integrin is prob- 
ably a  homolog of human VLA-5 integrin (3).  Immuno- 
morphological data have also demonstrated the presence of 
VLA-1 and VLA-2 integrins in SMC of skin, lung, and blood 
vessels (20). 
In the present work, we concentrated on the study of  VLA-1 
integrin. The ot chain of VLA-1 integrin has a relative molec- 
ular mass of •200,000  D  and is complexed with the /~ 
chain of integrin to form a  functional heterodimer (ott/31) 
(21).  On human melanoma cells VLA-1 integrin acts as a 
receptor for basement membrane type IV collagen (28), and 
on  neurons,  for  laminin  (24).  Laminin-binding  integrin 
o~t~ was also isolated and characterized from rat hepato- 
cytes (10). Growth signals can readily alter the expression of 
VLA-1 integrin. The transforming growth factor-/3 markedly 
increases the expression of VLA-1 integrin in WI-38 human 
fibroblasts (17). The VLA-1 integrin expression is also en- 
hanced  in  quiescent  fibroblasts  (9).  In  a  neuroblastoma 
GRGDSP peptide-resistant cell line, the VLA-1 integrin was 
specifically overproduced (8).  Based on these observations 
and previously reported data concerning the ability of  VLA-1 
integrin to interact with type IV collagen and laminin, we 
hypothesized that the expression of VLA-I integrin in human 
SMC is phenotype dependent and can be altered during de- 
velopment. Herein, we describe the isolation, characteriza- 
tion, intracellular localization, and tissue distribution of hu- 
man SM VLA-1 integrin. We also provide data showing that 
the expression of VLA-1  integrin is dramatically changed 
during SMC cultivation and SM development. 
Materials and Methods 
Materials 
Laminin was commercially obtained from Bethesda Research Laboratories 
(Gaithersburg, MD). Human plasma fibmnectin was provided by Dr. M. A. 
Chernousov (USSR Cardiology Research Center,  Moscow,  USSR).  Puri- 
fied human type I, II, HI, and IV collagens and human plasma Clq protein 
were kindly provided by Dr.  S. Domogatsky (USSR Cardiology Research 
Center).  Human  platelet trombospondin was  a  generous  gift of Dr.  G. 
Samokhin (USSR Cardiology Research Center). 
Antibodies 
mAb 102DF7 against/~1 subunit of integrin was kindly supplied by Dr. I. 
Virtanen (Department of Anatomy, Helsinki University, Helsinki, Finland) 
(49).  Rabbit anti-Bi  cytoplasmic  domain  polyclonal  antibodies  were  a 
generous gift of Dr. R. Hynes (Massachusetts Institute of Technology, Cam- 
bridge, MA) (31). mAb TS2/7 against cq subunit of VLA-I integrin (20) 
was from T  Cell Sciences (Cambridge, MA). Pulyclonai antibodies to cq 
subunit of VLA-I integrin were prepared as described below. Folyclonal an- 
tibodies against COOH terminus (13 mer) of c~5 subunit of VLA-5 integrin 
(fibronectin receptor) were kindly provided by Dr. E. Ruoslahti (La Jolla 
Cancer  Research  Foundation,  La  Jolla,  CA).  Polyclonal  antibodies  to 
chicken gizzard talin were a generous gift of Dr. K. Burridge (University 
of North Carolina, Chapel Hill, NC). 
Purification of Total SM f3~ Class Integrins 
All procedures were done at +4°C with exceptions specifically noted. 400 
g of SM from human uterus was homogenized in a Waring blender with 2.5 
liters of deionized water containing 0.5 mM PMSE After centrifugation (10 
min at 9,000 rpm in JA-10 rotor; Beckman Instruments, Inc., Berkeley, CA) 
the supernatant was discarded and the pellet was extracted in water with 0.5 
mM PMSE For extraction of peripheral membrane proteins the pellet was 
resuspended in 2.5 liters of buffer, containing 20 mM Tris,  1 mM EGTA, 
0.5 mM PMSE pH 9.0 (25, 27). The suspension was stirred for 60 rain at 
37°C.  Centrifugation was repeated and the superuatant was discarded. To 
solubilize myosin, tissue pellet was dissolved in 2 liters of buffer, containing 
20 mM Tris-HC1, 0.6 M KCI, 0.5 mM PMSE pH 7.4, stirring constantly 
for 60 min (27). The homogenate was centrifuged (as above) and the pellet 
was washed with 2.5 liters of water with 0.5 mM PMSE After centrifuga- 
tion, the pellet was extracted in 2 liters of buffer, containing 20 mM Tris- 
HC1, 0.5% Triton X-100,  1 mM CaC12,  1 mM MgCI2, 0.5 mM PMSE pH 
7.4, for 15 h with constant stirring. The detergent extract was cleared by 
centrifugation and then applied onto a column with 50 rng of anti-B1 mAb 
102DF7 coupled to 5 ml of cyanogen bromide-activated Sepharose.  The 
column was washed with 10 vol of extraction buffer, and then with 10 vol 
of buffer, containing 20 mM Tris-HC1, 0.1%  Triton X-100,  1 told CaCI2, 
1 mM MgC12,  1 M  NaCI,  pH 7.4.  Bound proteins were eluted with 200 
mM glycine-HCl, 0.1% Triton X-100, 1 mM PMSF, pH 2.2, and iramedi- 
ately neutralized with 0.1 vol of 1 M  Tris-HCl, pH 8.5 
Purification of VLA-I and VLA-5 lntegrins 
Type I collagen, type IV collagen, and fibronectin were coupled to cyanogen 
bromide-activated Sepharose (Pharmacia,  Uppsala,  Sweden) by standard 
technique. Triton X-100 detergent extract of uterus SM (20 mM Tris-HCl, 
0.5% Triton X-100, 1 mM CaCI2,  1 mM MgCI2, 0.5 mM PMSF, pH 7.4), 
obtained exactly as described above, was applied to columns with corre- 
sponding ligands. In some experiments,  1 mM CaC12 and  1 mM MgC12 
were substituted for 1 mM MnCI2 in the column buffer. Nonbound mate- 
rial was removed by washing with 10 vol of buffer, containing 20 mM Tris- 
HCI, 0.1% Triton X-10,  1 mM CaC12,  1 mM MgCI2, 0.2 M NaC1, pH 7.4. 
Elution of bound material was performed by washing the columns with 2 
vol of 20 mM Tris-HCl,  0.1%  Triton X-100,  10 mM EDTA, pH 7.4. 
For purification ofal suhnnit of VLA-1 integrin, 3--4 mg of eluate from 
collagen type I-Sepharose was subjected to preparative electrophoresis, and 
gel pieces, corresponding to 195-kD protein, were excised. Rabbits were 
immunized  subcutaneously  with  1  mg  of highly purified  o~  I  subunit in 
complete Freund's adjuvant. 4 wk later, the rabbits were boosted with 0.5 
mg of the antigen. Rabbit sera were collected and the IgG fraction purified 
by standard chromatography on a column of DE-52 cellulose. 
Immunoprecipitation and Immunoblotting 
Immunoprecipitation with anti-a1 subunit mAb TS2/7 was performed on 
crude Triton X-100 extracts and eluates from anti-Bl antibody-Sepharose 
or collagen type I-Sepharose. All protein preparations were extensively dia- 
lyzed against buffer, containing 20 mM Tris-HC1, 0.1% Triton X-100, I mM 
CaCI2,  1 mM  MgC12,  150 mM  NaCI,  0.5  mM  PMSF,  pH  7.4,  before 
precipitation. 4/tg of anti-al-specific antibodies was added to each sam- 
ple, containing an excess of VLA-I integrin. After incubation for 18 h  at 
+4°C,  100 ~1 of goat anti-mouse IgG coupled to Sepharose CL-4B  (5 
mg/ml of the gel) was added for 2 h. Immunoprecipitates were thoroughly 
washed  five times  in the immunoprecipitation buffer by centrifugation, 
eluted in SDS gel sample buffer, and subjected to electrophoresis. 
Immunoblottin  8 was done according to the procedure of Towbin et al. 
(46). Electrotransfer was carried out for 3 h at 400 mA current. The blots 
were  revealed  by  the  indirect  immunoperoxidase  technique  or  by  im- 
munoradiolabeling.  4-Chloro-l-naphtol (Sigma Chemical Co.,  St. Louis, 
MO) was used as a substrate for peroxidase,  m~I-Labeled goat anti-rabbit 
IgG (1/zg/ml; 107 cpm//~g sp act) was used as a secondary antibody for the 
study of the distribution of cq and/3t integrin subunits in human tissues 
and cell types. Immunoblots were dried and exposed to X-ray films (Tasma, 
USSR) for 48-96 h at -70°C to determine the positions of the polypeptides. 
Then the strips of nitrocellulose corresponding to cq or B~ subunits were 
cut out and radioactivity was measured in a ~/counter. The method was re- 
producible with repeated measurements on the same sample (i.e., the ratio 
of the SD to the mean was <5% of the mean). Radioactivity values changed 
linearly over the range of protein loadings used. 
SDS-PAGE was done on 7.5 or 5-15%  polyacrylamide slab gels with 
Laemmli's buffer system (29). Tissue or cell samples were dispersed imme- 
diately in Laemmli's electropboresis sample buffer, without B-mereapto- 
ethanol, and protein concentration was determined with BCA Protein Assay 
Reagent (Pierce Chemical Co., Rockford, IL). Each electropboretic sample 
contained 0.15 nag of total protein. After protein content estimation, 5% 
/3-mereaptoethanol was added and tissue or cell samples were bored for 5 
rain before electrophoresis. 
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Liposomes and Liposome  Binding  Assay 
Liposomes were prepared as described in references 33 and 37. VLA-I inte- 
grin of 95-98% purity, as judged by SDS-PAGE, was eluted with 20 mM 
Tris-HCl,  100 mM octylglucoside, 10 rnM EDTA, pH 7.4, from collagen 
I-Sepharose and used for incorporation into liposomes. A mixture of egg 
yolk phosphatidilicholine (Sigma Chemical Co.)  (800  ttg for liposome- 
binding  experiments)  and  200  ~tg  of  cholesteryl-[l-14C]-oleate  (53.1 
mCi/mmol sp act) was dried onto a glass tube under a stream of N2 and 
dissolved in TBS (25 mM Tris-HCl, 1 mM CaCI2,  1 mM MgCl2, pH 7.5), 
containing 100 mM octylglucoside or protein fractions (20 pg of VLA-I) 
in the same buffer.  Detergent was removed by extensive dialysis for 24 h 
at +40C.  To purify liposomes, the suspension was made 45% in sucrose, 
overlaid with 2 mi of 30% sucrose and I ml of 10% sucrose, and centrifuged 
at +4°C for 18 h at 45,000 rpm in an SW 50.1 rotor (Beckman Instruments, 
Inc.). The liposomes were recovered at the top of the 10%  sucrose layer, 
75-90% of VLA-1 was incorporated into lipid vesicles in standard experi- 
ments. In separate experiments both COOH- and NH2-terminal domains of 
the VLA-1 integrin ~1 subunit were shown to be exposed on the surface of 
liposomes, since polyclonal antibodies against COOH-terminal (intracellu- 
lar) Bl peptide and mAb 102DF7,  which recognizes the NHz-terminal (ex- 
traeellular) part of the/3, integrin molecule, wer  e able to precipitate lipo- 
somes containing VLA-1 integrin. 
For liposome-binding experiments type I, II, HI, and IV collagens, Clq, 
iamiuin, fibronectin, trombospondin, gelatin, and BSA were diluted in car- 
bonate buffer, pH 8.6, to a concentration of 25 t~g/mi and 200 td was used 
to coat microtiter walls (0.28 cm  2 surface area; Linbro, Flow Laboratories, 
Hamden, CT) by incubation overnight at +40C. Wells were washed twice 
with TBS and blocked for I h with TBS plus 10 mg/mi BSA. Labeled iipo- 
somes (100 or 200/~1;  105 cpm/well sp act) suspended in TBS with 2 mg/mi 
BSA were allowed to attach for 16 h at +40C. Then the supernatants were 
removed and the wells were washed three times with TBS. Bound liposomes 
were dissolved in 1% SDS and radioactivity was counted in a scintillation 
counter. In some experiments, 10 mM EDTA or synthetic peptides GRGDSP 
and GRGESP (1 mg/ml final concentration) were added to the wells. 
Human tissue Samples 
Human fetal tissue was obtained from fetuses aborted either spontaneously 
or on medical grounds. Child and adult tissues were obtained at autopsies 
taken within 2-4 h of death. At least five independent samples were ana- 
lyzed for each tissue. SD to the mean of ~1~1 ratios, were <10%  of the 
mean. Normal segments of the aorta from 35-45-yr-old donors were ana- 
lyzed. For immunoblotting analysis, aortas were longitudinally opened, ad- 
ventitia were discarded, and the endothelium was removed mechanically. 
Normal segments were separated and divided into three layers: medial and 
two intimal, the subendothelial and the muscular-elastic (adjacent to the 
media) sublayers. 
Immunofluorescence 
Freshly isolated human aortic segments were immersed in freezing isopen- 
tane. 3--4-t~m-thick longitudinal and transverse cryostat sections were pre- 
pared at -20"C. Sections were mounted on glass slides. For double-indirect 
immunofluorescence,  sections were  incubated  with  mouse  monoclonal 
anti-~l TS2/7 antibody (1:20) and rabbit anti-~l antibodies (1:100) for 1 h 
at 37"C.  Sections were washed in PBS for 30 min and then fluorescein- 
conjugated goat  anti-mouse IgG  (1:50)  and rhodamine-conjugated goat 
anti-rabbit IgG (1:50) were added. After a further incubation for 45 rain, 
the sections were washed and mounted in PBS with 50% (vol/vol) glycerol. 
The  stained sections were examined under a  Zeiss epifluorescent pho- 
tomicroscope HI. Photographs were taken with Kodak Tri-X-film.  In all ex- 
periments,  immunofluorescence was  specific: no staining was observed 
when antibodies were preabsorbed with corresponding antigens or when 
nonimmune IgG was used. 
Cell Culture 
SMC from human aortic media were isolated by collagenase-elastase diges- 
tion  of the  tissue  (6)  and  cultured  in  DME  (Flow Laboratories,  Inc., 
McLean, VA) supplemented with 10 mM HEPES, 100 ttg/ml sodium pyru- 
vate, 50/tg/ml ascorbic acid, 0.6 mg/ml L-glntamine, 50 t~g/ml gentamicin 
sulfate, and 10% heat-inactivated human serum. For immunofluorescence, 
sterile glass coverslips were  coated  with type  I  and  IV  collagens and 
fibronectin (50/~g/ml) in PBS for 1 h at 37"C. After removing excess protein 
solutions, the coverslips were treated with 0.2% glutaraldehyde in PBS for 
15 min at 37"C, washed with sterile PBS, and used for cell plating. Human 
skin fibroblasts (growing or quiescent), human umbilical vein endothelial 
cells, and human keratinoeytes (34) were kindly provided by Drs. O. Or- 
natsky and M.  Lukashev (USSR Cardiology Research Center). Platelets 
were isolated and purified from human plasma. 
Results 
Identifuration and Isolation of VLA-1 Integrin  from 
Human SM 
Total VLA integrins from human uterus SM were purified 
using affinity  chromatography on an anti-/3~ mAb coupled 
to Sepharose 4B. A crude extract  of membrane proteins in 
Triton X-100 contained a number of polypeptides,  ranging 
in molecular masses from 20 to 250 kD (Fig.  1 A, lane a). 
After affinity  chromatography  on anti-B,-Sepharose,  four 
major polypeptides were bound and specifically eluted from 
the column. Apparent Mr values of 130,  165,  195,  and 235 
kD were determined for these proteins, as judged by SDS- 
PAGE under reduced conditions (Fig. 1 A, lane b). Based on 
its electrophoretic mobility and immunoblotting results (Fig. 
1 B, lanes a and b) the lower band was identified as the B, 
integrin subunit. A major integrin subunit of 195 kD, which 
eluted  together  with  fll  subunit  from  the  column,  was 
shown  to  be  an  c~  integrin,  since  this  polypeptide  was 
precipitated from a crude Triton X-100 extract or from an 
anti-B~-Sepharose eluate when anti-oil subunit  mAb TS2/7 
was used (Fig.  1 D, lanes a and b). The presence of or5 inte- 
grin subunit  in Triton X-100 extract and anti-/31-Sepharose 
eluate was also verified by immunoblotting (Fig.  1 C, lanes 
a and b). These results indicate that human SM contains sev- 
eral different ot subunits  of/~, subfamily (or1, ors, and proba- 
bly others), and ot~ integrin was shown to be a predominant 
subunit among Brassociated SM integrins. We were unable 
to determine the identity of two other integrin bands of 165 
and 235 kD. The 165-kD polypeptide was not recognized by 
a polyclonal antibody against or2 integrin subunit  (data  not 
shown). 
Ligand affinity  chromatography was used to purify func- 
tional VLA-1  and VLA-5 SM integrins. Based on the previ- 
ously obtained data concerning the ligand specificity of VLA-1 
integrin, we used collagen type IV-Sepharose column for the 
affinity  purification of the integrin receptor.  Two polypep- 
tides of 195 and 130 kD, as well as some other minor bands, 
were seen on SDS-PAGE of collagen type IV-Sepharose elu- 
ate (data not shown). When the same affinity chromatogra- 
phy experiment was done using collagen type I-Sepharose 
matrix, only two components migrating on SDS-PAGE as 
195- and 130-kD bands were revealed (Fig.  1 A, lanes c and 
d).  Molecular masses of these polypeptides,  immunoblot- 
ting (Fig. 1 B, lanes c and d), and immunoprecipitation data 
(Fig. 1 D, lane c), confirmed the correspondence of purified 
proteins to c~ and/3~  integrin subunits  of the VLA-1  com- 
plex. Total yield of 5-6 mg of VLA-1  integrin was purified 
from 400 g of uterus SM tissue. When the same procedure 
was  performed  with  fibronectin-Sepharose,  1.5-2  mg  of 
VLA-5 was obtained (data  not shown). 
To raise polyclonal antibodies to o~, subunit  of SM inte- 
grins,  suitable  for  immunoblotting  experiments,  we  im- 
Belkin et al.  VLA-1 lntegrin in Human Smooth Muscle  2161 Figure 1. Analysis of human uterus SM VLA integrins. (A) Coomassie blue-stained  SDS-polyacrylamide gels of (lane a) crude Triton 
X-100 extract from uterus SM; (lane b) eluate from anti-/$~-Sepharose; (lane c) eluate from collagen type I-Sepharose in reducing condi- 
tions; (lane d) eluate from collagen type I-Sepharose  in nonreducing conditions. (B) Immunoblots of the gels (lanes a-d) from A with 
polyclonal anti-/3~-integrin  antibody. (C) Immunoblots of the gels (lanes a-d) from A with polyclonal anti-as-integfin  antibody. (D) lm- 
munoprecipitation analysis of a, subunit of VLA integrins with TS2/7 anti-a, mAb. Immunoprecipitated proteins were visualized by 
Coomassie blue staining of SDS-polyacrylamide gels. (Lane a) at and/~m subunits of VLA integrin were precipitated from crude Triton 
X-100 extract of human uterus SM; (lane b) al subunit of VLA integrin was precipitated from anti-/31-Sepharose  eluate. Absence of/~, 
subunit in immunoprecipitate is due to dissociation of at and/~ subunits during the elution of VLA-I integrin from anti-/~rSepharose 
(pH < 3.5) (21); (lane c) a, and/St subunits of VLA integrin were precipitated from collagen type I-Sepharose eluate. The lower bands 
in all gels are IgG heavy chains. (E) Immunoblots of the gels (lanes a and d) from A with polyclonal anti-195-kD protein antibody. (F) 
Immunoblots of anti-a~ subunit TS2/7 antibody immunoprecipitate from crude Triton X-100 extract of human uterus SM with polyclonal 
anti-195-kI) protein antibody. Molecular mass markers of 250, 200,  150, 130, and 100 kD are denoted to the left of the gels. 
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Figure 2. Binding of  VLA-I integrin-containing liposomes to adhe- 
sive proteins.  Microtiter wells were coated with type I collagen 
(CI), type IV collagen (C/V), laminin (LN), fibronectin (FN), and 
bovine serum albumin (BSA). The binding of VLA-I integrin-con- 
talning liposomes was determined in the presence of 1 mM Ca  2+ 
and  1 mM Mg  2+. 
munized rabbits with pure or1 subunit obtained by prepara- 
tive  electrophoresis.  The  resulting  polyclonal  antibodies 
recognized only a protein of 195 kD in immunoblotting of 
crude Triton X-100 extract of uterus SM and eluates from 
anti-/31-Sepharose and collagen type I-Sepharose (Fig.  1 E, 
lanes a-d). Finally, the specificity of the polyclonal antibod- 
ies  was  confirmed by their reaction with the polypeptide 
precipitated  from  the  crude  Triton  X-100  extract  with 
anti-a1 subunit mAb (Fig.  1 F). Further, we used these an- 
tibodies for the investigation of VLA-1 distribution in human 
tissues and cultured cells. 
Substrate Specificity of  Human SM VLA-1 Integrin 
To investigate ligand  binding  of the  SM  VLA-1  integrin, 
C~4-1abeled liposomes containing the VLA-1  integrin were 
prepared by detergent dialysis. As shown in Fig. 2, VLA-1 
integrin-containing liposomes were able to bind to type I 
and  IV  collagens  and  laminin  substrates  immobilized on 
polystyrene fiat-bottom wells,  and these interactions were 
concentration dependent. At the same time, VLA-1 incorpo- 
rated  in  liposomes  did  not  interact markedly  with  other 
adhesive proteins, e.g., fibronectin or BSA. 
Next, we tested different extracellular matrix proteins and 
plasma components as putative ligands for VLA-1  integrin. 
VLA-l-containing  liposomes  were  capable  of binding  to 
type I, II, HI, and IV collagens, laminin, and Clq subcompo- 
The Journal of Cell Biology, Volume 111, 1990  2162 X 
E 
Q. 
o 
v 
r~ 
Z 
0 
m 
O9 
W 
0 
0 
1.5: 
0.~ 
0 
CI  G  CII  CIII  N 
CIV  LN  C1¢  FN 
SUBSTRATE 
N 
TSP  BSA 
Figure 3.  Substrate specificity of liposomes containing 
human  SM VLA-1 integrin.  Substrates were prepared 
with type I, II, III, and IV collagens (CI, CII, CIII, and 
C/V), gelatin (G), laminin (LN), Clq subcomponent of 
the first component of the complement (Clq), fibronectin 
(FN), thrombospondin (TSP), and BSA. Binding to all 
other substrates was determined in the presence of 1 mM 
Ca  2+ and 1 mM Mg  2+. 
nent of the complement cascade, which contains a collagen- 
like domain (Fig.  3). In our expe  "runental  conditions, type 
I  collagen was the best substrate  for VLA-l-bearing lipo- 
somes. In contrast, VLA-1 integrin, integrated in liposomes, 
did not bind to  fibronectin and trombospondin.  Negative 
controls showed that omission of the VLA-1 integrin almost 
completely eliminated the binding of liposomes to any sub- 
strate (data not shown). VLA-l-containing liposomes were 
unable to interact with gelatin, or BSA-coated wells. VLA-1 
liposome binding  to  corresponding ligands  was  observed 
only in the presence of 1 mM Mn  2+ (or  1 mM Mg  2+ and 
Ca  ~÷)  in  the  incubation buffer.  EDTA-containing medium 
strongly (7-10 times) inhibited interactions of VLA-1  inte- 
grin with type I, IT, HI, and IV collagens, laminin, and Clq 
protein. Using GRGDSP peptide in these experiments, we 
found that SM VLA-1 integrin interacts with different adhe- 
sive  proteins  in  an  RGD-independent  manner  (data  not 
shown). 
Distribution of VLA-1 Integrin in Human 1Tssues and 
Cell 1),pes 
To determine the distribution of VLA-1  integrin in various 
human tissues and cultured cells, the samples were examined 
by SDS-PAGE and quantitative immunoblotting was done 
with antibodies recognizing ot~ and/3, subunits of SM VLA-1 
integrin. Experimental results are shown in Fig. 4 and Table 
I.  Various  amounts  of or,  and/~  subunits  were found  in 
different  human  tissues  and  cultured  cells.  The  largest 
amount of VLA-1  integrin appeared to be present only in 
SM.  Striated muscles,  skin,  endothelial cells,  fibroblasts, 
platelets,  and  keratinocytes  contained  trace  amounts  of 
VLA-1 integrin. Therefore, we conclude that (a) SM can be 
the best source for VLA-1 integrin isolation and (b) high lev- 
els of VLA-1  integrin expression are a characteristic prop- 
erty of SMC. 
Figure 4. Quantitative analysis of t~l and 
~1VLA integrin subunit content in differ-. 
ent human tissues and cultivated cells by 
SDS-PAGE, immunoblotting, and subse- 
quent autoradiography. (Lane a)  Uterus 
SM; (lane b) cardiac muscle; (lane c) skel- 
etal muscle; (lane d) skin; (lane e) brain; 
(lane f) skin fibroblasts (growing); (lane 
g) skin fibroblasts (quiescent); (lane h) en- 
dothelial cells; (lane i) platelets; (lane k) 
keratinocytes; and (lane 1) purified VLA-1 
integrin. 
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in Human  Tissues and Cultured Cells 
Source  cq  fll  ott/~l 
cpm  x  10  -s  cpm  × 10  -s 
Uterus smooth muscle  47.5  101.0  0.47 
Cardiac muscle  0.4  ND  ND 
Skeletal muscle  0.2  ND  ND 
Skin  0.24  9.8  0.02 
Brain  1.3  9.2  0.14 
Skin tibroblasts (growing)  3.6  108.0  0.03 
Skin fibroblasts (quiescent)  4.5  102.0  0.04 
Endothelial cells  3.2  233.0  0.01 
Platelets  0.8  56.0  0.01 
Keratinocytes  9.0  186.0  0.05 
Purified VLA-1 integrin  74.6  94.2  0.79 
Expression of VLA-1 Integrin in Human Aortic SM 
Fetal Aorta. The distribution of a, and 3~ subunits of VLA 
integrin was studied in aortas of 9-10- and 24-wk-old human 
fetuses and in the mesenchyme surrounding the  10-wk-old 
aorta.  Cryostat  sections  of the  fetal  aorta  were  double 
stained with mouse mAb TS2/7 to al subunit of VLA inte- 
grin and with rabbit polyclonal antibody to 3, subunit of 
integrin (Fig.  5).  The whole aortic wall of 10-wk-old fe- 
tuses was stained with both antibodies (Fig. 5, a and b), thus 
revealing the expression of VLA-1 integrin in the 10-wk-old 
fetal vascular SM. On the contrary, very weak staining with 
antibodies against at subunit of VLA integrin was observed 
in the aorta of the 24-wk-old and in the mesenchyme of the 
10-wk-old fetuses. At the same time the sections were posi- 
tively stained with antibodies to 3m subunit of integrin (Fig. 
5, c and d). Immunoblotting data were consistent with the 
results of immunofluorescence studies (Table II and Fig. 6 
A, lanes a and b). The content of VLA-1  integrin in the ex- 
tract of 9-10-wk-old fetal aorta was obviously higher than in 
the extract of 24-wk-old fetal aorta. Thus, in aortic samples 
of the 24-wk-old fetus the ot~ subunit content was 4.3-fold 
lower and  the  31  subunit content,  only 2.5-fold lower as 
compared with samples of the 9-10-wk-old embryos. 
Child Aorta.  Immunoblotting analysis of extracts from 
child aorta indicates that during the postnatal period of hu- 
man vascular SM development the content of VLA-1 integrin 
increases (Table II and Fig. 6 A, lanes c-e). The content of 
am subunit of VLA integrin in 3-mo-old child aortic media 
was three times higher compared with 24-wk-old fetus aorta. 
In 12-yr-old aortic media the amount of a~ subunit was two 
times greater than in 3-mo-old child aorta. The at~31 ratio 
also increased 1.6-fold in the aorta from 3-too-old child, 2.4- 
fold in the aorta from 1.5 yr-old child, and 3.4-fold in the 
aortic media from 12-yr-old child as compared to that in the 
24-wk-old fetus. Only in 1.5-yr-old child aorta the share of 
al subunit approached the level characteristic of adult aortic 
medial SM. Thus, the significant changes of VLA-1 integrin 
content occurred not only during prenatal development, but 
also during several months after birth (Table lI and Fig. 6 A). 
Adult Aorta. In the adult human aorta, SMC occupy two 
anatomical layers; tunica media and tunica intima (38). Tun- 
ica intima is formed during postnatal growth, and the adult 
aortic  intima  can  be  divided into  two  sublayers:  suben- 
dothelial and muscular-elastic (adjacent to the media) (38). 
Both intimal sublayers and media of the human aorta were 
mechanically separated and assayed for the content of a~ 
and 3t VLA integrin subunits. In media and in both intimal 
sublayers, at subunit, as well as/~1 subunit of VLA integrin 
were detected (Table II and Fig. 6 B). However, the content 
of am  subunit of VLA integrin differed depending on the 
layer. The amount of #j subunit of integrin in all layers was 
practically the same (Table II). In subendothelial intima, at 
subunit  content was  significantly decreased as  compared 
with that in adjacent muscular-elastic intima and media (Ta- 
ble II). The aJ/~ ratio was 0.11 in subendothelial SMC and 
,,00.5 in muscular-elastic intimal and medial SMC. 
For detailed investigation of  VLA-1 integrin distribution in 
adult human aorta SMC, cross sections of grossly normal 
segments of the aorta (from 35--45-yr-old donors) were dou- 
ble stained with antibodies to a~ and 81 subunits of VLA-1 
integrin. A positive staining of SMC with anti-3~ antibody 
was observed in all layers of adult human aorta (Fig. 7). A 
strong positive staining was also observed with anti-a1 an- 
tibody in medial and muscular-elastic intimal SMC. On the 
contrary,  immunofluorescence  of  subendothelial  intimal 
SMC stained by anti-a~ antibody was rather weak (Fig. 7, 
e  and f).  The  majority  of subendothelial  intimal  SMC 
demonstrated a low level of VLA-1 integrin expression; how- 
ever, some cells were VLA-1 integrin negative (Fig. 7 e). In 
other experiments it was shown that VLA-1 integrin-negative 
cells were positively stained with SM isoactin-specific anti- 
body, proving the SM origin of these cells (data not shown). 
VLA-1 Integrin in Cultured SMC  from Human 
Aduit Aorta 
To determine cellular localization of the VLA-1  integrin, 
freshly isolated human  aortic SMC,  grown  for  1 wk  on 
coUagen-coated coverslips, were examined by indirect im- 
munofluorescence microscopy. Earlier, it was shown that on 
the seventh day of cultivation, SMC have a well-developed 
fibronectin-containing extracellular matrix (13).  The cells 
were  stained  using  antibodies  against  human  a~  and  as 
subunits of VLA integrin,  against 31  subunit of integrin, 
and against talin. In general, two main types of a~ integrin 
localization were found in primary SMC cultured on type I 
collagen substrate. The cq subunit of VLA-1  integrin had a 
patcldike distribution on the ventral cell surface (these sites 
correspond to focal adhesion sites [28]) and was revealed as 
a streaklike pattern that coincided with extracellular matrix 
attachment sites (Fig. 8, a, c, and e). The intracellular local- 
ization of the 3~ subunit of VLA integrin was very similar, 
hut in addition some parts of the protein were randomly dis- 
tributed on the upper cell surface membrane (Fig. 8, a and 
b). We always found a good correspondence in the distribu- 
tion patterns of a~ and a5 subunits, and between al subunit 
of VLA-1  integrin and talin (Fig. 8, c-f). We were unable 
to identify any subcellular sorting of the a~ and a5 subunits 
of VLA integrins on type I collagen substrate, most likely 
because of a  well-developed fibronectin-rich extracellular 
matrix characteristic of primary SMC cultures (28). Thus, 
cultivated SMC contain VLA-1, VLA-5 integrins, and talin 
at the same cell-substrate and cell-matrix attachment sites. 
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staining of human fetal aorta 
sections  with  antibodies  to 
VLA-1 integrin subunits. Cross 
sections  of  10-wk-old  fetal 
aorta (a and b) and 24-wk-old 
fetal aorta (c and d) were dou- 
ble  labeled  with  fluorescein 
anti-Otl-SUbunit and rhodamine 
anti-Brsubunit of VLA-1 in- 
tegrin. (a and c) anti-at sub- 
unit;  (b and d)  anti-B1 sub- 
unit. In lO-wk-old fetal aorta 
(a),  al  subunit  staining was 
seen only in SMC, while the 
surrounding mesenchyme was 
C~l-negative (indicated by the 
arrow). Bars, 20 #m. 
To determine whether the amount of VLA-1  integrin was 
altered during SMC cultivation, we estimated the content of 
al and/31  subunits of VLA integrin in primary culture and 
subcultures of SMC by quantitative immunoblotting. In our 
experimental conditions, SMC isolated from tunica media of 
human aorta did not proliferate up to 10-12 d in culture. In 
the course of primary culture, the content of at subunit of 
VLA integrin significantly decreased (Table II and Fig. 6 C). 
At the same time, the share of 13m subunit of integrin did not 
change.  The ot~/B~ ratio of VLA integrin in cells cultured 
for 2 d was 0.41, and in cells grown in culture for 10 d the 
ct~//$1 ratio was 0.06 (Table 11). The otl//~l ratio of VLA inte- 
grin in subcultured SMC from media of human aorta (8 pas- 
sage) was very low and did not differ from that of proliferat- 
ing cells in primary culture. 
Discussion 
In this report, we describe the purification of a complex con- 
sisting of two polypeptides of 195 and 130 kD from human 
uterus SM. The following independent criteria show that this 
complex might be VLA-1 integrin. First, the electrophoretic 
Belkin et al. VLA-I lntegrin  in Human  Smooth Muscle  2165 Table II. Relative Amounts of ~l Subunit of VLA-1 Integrin 
in Human Aorta and Cultured Aortic SMC 
Source of smooth  muscle  c~  cpm x 10  -3  cll/Bl 
9-10-wk-old fetal aorta  13.0  48.3  0.27 
24-wk-old fetal aorta  3.0  19.0  0.16 
3-mo-old child aorta  9.1  35.0  0.26 
1.5-yr-old child aorta  14.3  38.1  0.38 
12-yr-old aortic media  18.4  33.6  0.54 
Adult aorta wall layer 
Media  14.9  32.4  0.46 
Muscular-elastic intima  16.3  28.8  0.57 
Subendothelial intima  3.8  35.7  0.11 
Cultured aortic medial cells 
Primary culture (2 d)  77.6  190.0  0.41 
Primary culture (10 d)  10.1  174.0  0.06 
Subculture (8th passage)  2.0  159.0  0.01 
mobilities of the polypeptides in reduced and nonreduced 
conditions correspond  to  al  and /31  subunits of classical 
VLA-1 integrin found in T cells. Second, the 130-kD poly- 
peptide interacts specifically with defined monoclonal and 
polyclonal  antibodies  to  human  B1  subunit  of  integrin. 
Polyclonal antibody used in the present study is directed 
against the COOH-terminal domain of the BI subunit in hu- 
man tissue (31). The 195-kD polypeptide was able to interact 
with a well-characterized mAb, TS2/7, which was originally 
developed for the identification and isolation of o~ subunit 
of VLA-1  integrin from T  ceils (20).  Third, the  195- and 
130-kD polypeptides were able to form a stable heterodimer 
solubilized in nonionic detergents. This heterodimer, precip- 
itated in the absence of detergent, could be effectively  incor- 
porated into liposomes, thus acting as an integral membrane 
protein. Finally, this heterodimer, isolated from human SM, 
exhibited functional properties characteristic of receptors to 
extracellular matrix proteins. 
Functional Properties of  Human SM VLA-1 Integrin 
Our results show that human SM VLA-1, being incorporated 
into liposomes, specifically interacts with basement mem- 
brane components, laminin, and type IV collagen, as well as 
with interstitial type I, II, and HI collagens. It ought to be 
noted, that in contrast to previously published data (28), the 
affinity of SM VLA-1  integrin to type I  collagen was the 
highest and exceeded that to type IV collagen. Thus, these 
data contradict the widely held concept that differentiated 
human SMC are predominantly surrounded by type IV colla- 
gen and laminin. However, the possibility that VLA-1 bind- 
ing to type I collagen takes place at the early stages of em- 
bryogenesis, when SM precursor cells are in close contact 
with interstitial collagens, cannot be excluded. Furthermore, 
since we were unable to identify any VLA-2 integrin (con- 
sidered to be the major integrin receptor for type I collagen 
[28]) in total SM extract, it seems to us that high affinity of 
SM VLA-1 integrin to type I collagen is important for the 
interaction of SMC with extracellular matrix. Affinity chro- 
matography of SM integrins on collagen type I-Sepharose 
failed to detect any other collagen-binding integrins besides 
VLA-I. Thus, VLA-I integrin has functional  properties char- 
acteristic of integrins with a broad spectrum of specificity, 
interacting with extracellular matrix proteins in an RGD- 
independent manner. 
Data reported in this study, as well as those published by 
other groups (3,  25,  48),  indicate that VLA-1  and VLA-5 
integrins are the major VLA integrins in human SM and can 
serve as receptors for laminin, fibronectin, basement mem- 
brane, and interstitial collagens. Apart from VLA integrins, 
SMC also express the/33  subfamily of integrins (7), which 
potentially promote the adhesion of SMC to vitronectin, 
thrombospondin,  fibrinogen,  and  yon Willebrand  factor. 
Thus, at least three different integrins, VLA-1, VLA-5, and 
the B3 subclass integrin(s), are needed to provide the inter- 
actions of SMC with all known extracellular matrix proteins. 
Based on the fact that VLA-1 integfin has a high affinity 
to native collagens, we tested the interaction between VLA-1 
integfin-containing liposomes and Clq subcomponent of the 
first component of the complement. A possible interaction 
between these two proteins was predicted by the presence of 
collagen-like domains in the Clq subcomponent molecule 
(36).  We were able to demonstrate specific interaction be- 
tween VLA-1 integrin-containing liposomes and Clq-coated 
surfaces. As known, VLA-1 integrin expression is dramati- 
cally enhanced in very late activated peripheral blood T cells 
(19). It has been suggested that in activated T lymphocytes 
VLA integfins are involved in cell-matrix interactions (18). 
The data obtained in the present study led us to speculate 
Figure 6.  Quantitative analysis of ¢1 and  /31 
VLA integrin subunit content in human aorta 
and cultivated aortic SMC by SDS-PAGE, im- 
munoblotting, and  subsequent autoradiogra- 
pby. (,4) Developing human aorta:  (lane a) 
9-10-wk-old fetal aorta; (lane b) 24-wk-old fe- 
tal aorta; (lane c) 3-mo-old child aorta; (lane 
d) 1.5-yr-old  child aortic media; (lane e) 12-yr- 
old aortic media. (B) Adult human aorta: (lane 
a)  media;  (lane b)  muscular-elastic intima; 
(lane c) subendothelial intima. (C) Cultivated 
aortic SMC: (lane a)  primary culture, 2  d; 
(lane b) primary culture, 10 d; (lane c) subcul- 
ture, 8th passage. 
The Journal of Cell Biology,  Volume 111, 1990  2166 Figure 7. Immunofluorescence staining of human adult aortic intima and media sections with antibodies to VLA-1 integrin subunits. Trans- 
verse sections of adult aortic media (a and b), and muscular-elastic (c and d) and subendothelial (e and f) intima were double labeled 
with fluorescein anti-,~-subunit and rhodamine anti-Bl-subunit of VLA-1  integrin. (a, c, and e) Anti-o0 subunit; (b, d, and f) anti-/3~ 
subunit. In the subendothelial intima (e), SMC negatively stained with antibodies to o[  1 subunit were seen (indicated by the arrow). Bars: 
(a, b, e, and f) 20 ton;  (c and d)  10 #m. 
Belkin et al. VLA-1  lntegrin in Human Smooth Muscle  2167 Figure 8. Immunofluorescent analysis of c~, c~, 151 integrin subunit and talin localization in primary cultured human aortic SMC, grown 
on type I collagen. Cells were double labeled with fluorescein anti-c~  subunit of VLA integrins (a, c, and e) and with rhodamine anti-~5~ 
subunit of VLA integrins (b); with rhodamine  anti-c~5 subunit of VLA integrins (d); with rhodamine  anti-talin (f). Bar, 10 pm. 
that at least one member of the VLA family, namely VLA-1 
integrin, is responsible for the involvement of T cells in the 
complement pathway via the interaction between T cells and 
Clq  subcomponent of the  first component of the  comple- 
ment. Therefore, T cell interaction with target cell antigens 
may be dependent on the presence of some complement sys- 
tem components such as the Clq subcomponent. The appear- 
ante of Clq subcomponent on the cell surface can probably 
promote formation of complexes between  T  lymphocytes 
and target cells. 
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Aortic SMC Development and Differentiation 
We have been interested in the mechanism(s) by which com- 
ponents of the extracellular matrix and the cytoskeleton were 
involved  in the development and differentiation  of human 
aortic SMC (2, 11-16). The evidence presented in this paper 
suggests that  VLA-1 integrin  is a differentiation  marker of 
human aortic SMC and can play an important regulatory role 
in the control of SM development. The following facts sub- 
stantiate our conclusion: (a) Human SMC express very high 
levels of VLA-1 integrin.  Mesenchymal cells and cells de- 
rived  from the mesenchyme,  such as  fibroblasts  and  en- 
dothelial cells, contain relatively  small amounts (compared 
to SMC) of VLA-1 integrin on their surface.  (b) Expression 
of VLA-1 integrin  significantly  changes during prenatal and 
postnatal development of the human aortic SM. (c) Pheno- 
typic modulation of SMC in culture (during transition  from 
the contractile to the synthetic  state [6]) is accompanied by 
a  dramatic  drop  in  the  VLA-1 integrin  expression.  In 
differentiated  (contractile)  SMC the VLA-1 integrin  content 
is remarkably high,  whereas in dedifferentiated  (synthetic) 
SMC, the amount of VLA-1 integrin  is rather low. 
The development of the human aorta is characterized by 
nondifferentiated  SMC becoming fully differentiated  and al- 
tering their phenotype several times (14, 15, 26, 35). Signals 
controlling  SMC differentiation  remain as yet unknown.  Re- 
cent studies have shown that VLA integrins may play an im- 
portant role as mediators of signal transduction controlling 
the  differentiation  of skeletal  muscles  (32).  Our  results 
clearly demonstrate that during development vascular SMC 
alter the expression of VLA-1 integrin  at least four times. 
During the prenatal  period, expression of VLA-1 integrin 
changes twice: before 8-10 wk of gestation,  conceivably, 
when mesenchymal cells begin to differentiate  into SMC, 
and between the 10th and 20th weeks of gestation.  Another 
change in VLA-1 integrin expression occurs during postnatal 
development, during the first year after birth, and in the adult 
aorta, when SMC are recruited into the intimal  cell popu- 
lation. 
Various signals  from the cell's environment  can alter the 
expression of VLA integrins.  Transforming  growth factor- 
/3~ elevates  the synthesis  of VLA-1 integrin  in WI-38 lung 
fibroblasts and in Hep (32 hepatoma cells (17). Growth con- 
ditions  also affect  VLA-1  integrin  expression.  In  rapidly 
growing normal human fibroblasts  the level of VLA-1 inte- 
grin is decreased, whereas in quiescent fibroblasts,  the ex- 
pression of VLA-1 integrin is greatly enhanced (9). All these 
experimental  data might  be of significance  in the under- 
standing  of the regulation of VLA-1 integrin  expression in 
human aortic SMC. A large body of evidence indicates  that 
during vessel development the expression of growth factors 
is varied.  Thus, fetal SMC produce PDGF while the adult 
cells do not (30, 44). Otherwise, in adult media, SMC are 
present in a quiescent, contractile state (43).  On the other 
hand, the functional relevance of differential VLA-1 integrin 
expression during SM development might be consistent with 
the  fact  that  the  expression  of  VLA-1 integrin  ligands 
changes also.  For instance,  during  vessel wall formation 
fibronectin appears before laminin  in the SMC extracellular 
matrix  (39).  Arrangement  of  the  basement  membrane 
around SMC often correlates with SM differentiation  and 
maturation.  Basement membrane proteins such as laminin 
and type IV collagen, being ligands for VLA-1 integrin,  ap- 
pear at the last stages of SM development and possibly pro- 
mote  terminal  differentiation  of SMC  and/or  the  main- 
tenance of differentiated  state through  the interaction  with 
VLA-1 integrin. 
In conclusion, we have shown that (a) human SM contains 
high amounts of VLA-1 integrin;  (/7) VLA-1 integrin  is able 
to interact with all types of collagens assayed,  with laminin 
and Clq subcomponent of the first component of the comple- 
ment system;  (c) in primary cultured SMC VLA-1 integrin 
was found to be present in focal contacts and extracellular 
matrix attachment sites;  (d) the expression of VLA-1 inte- 
grin in human aortic SMC is developmentally regulated and 
is characteristic  only of differentiated  SMC. 
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